The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 01, 2006
Filed:
Sep. 03, 2003
Timothy J. Guzi, Chatham, NJ (US);
Kamil Paruch, Garwood, NJ (US);
Michael P. Dwyer, Scotch Plains, NJ (US);
Ronald J. Doll, Convent Station, NJ (US);
Viyyoor M. Girijavallabhan, Parsippany, NJ (US);
Chad Knutson, Garwood, NJ (US);
Brian Mckittrick, New Vernon, NJ (US);
Lawrence W. Dillard, Skillman, NJ (US);
Vinh D. Tran, Fountain Valley, CA (US);
Zhen Min He, Princeton, NJ (US);
Ray Anthony James, Bristol, PA (US);
Haengsoon Park, Plainsboro, NJ (US);
Timothy J. Guzi, Chatham, NJ (US);
Kamil Paruch, Garwood, NJ (US);
Michael P. Dwyer, Scotch Plains, NJ (US);
Ronald J. Doll, Convent Station, NJ (US);
Viyyoor M. Girijavallabhan, Parsippany, NJ (US);
Chad Knutson, Garwood, NJ (US);
Brian McKittrick, New Vernon, NJ (US);
Lawrence W. Dillard, Skillman, NJ (US);
Vinh D. Tran, Fountain Valley, CA (US);
Zhen Min He, Princeton, NJ (US);
Ray Anthony James, Bristol, PA (US);
Haengsoon Park, Plainsboro, NJ (US);
Schering Corporation, Kenilworth, NJ (US);
Pharmacopeia Drug Discovery, Inc., Princeton, NJ (US);
Abstract
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.